JAK inhibitor has the amelioration effect in lupus-prone mice: the involvement of IFN signature gene downregulation

BACKGROUND: We previously reported that JAK–STAT-pathway mediated regulation of IFN-regulatory factor genes could play an important role in SLE pathogenesis. Here, we evaluated the efficacy of the JAK inhibitor tofacitinib (TOFA) for controlling IFN signalling via the JAK–STAT pathway and as a thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikeda, Keigo, Hayakawa, Kunihiro, Fujishiro, Maki, Kawasaki, Mikiko, Hirai, Takuya, Tsushima, Hiroshi, Miyashita, Tomoko, Suzuki, Satoshi, Morimoto, Shinji, Tamura, Naoto, Takamori, Kenji, Ogawa, Hideoki, Sekigawa, Iwao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568047/
https://www.ncbi.nlm.nih.gov/pubmed/28830352
http://dx.doi.org/10.1186/s12865-017-0225-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568047/
https://www.ncbi.nlm.nih.gov/pubmed/28830352
http://dx.doi.org/10.1186/s12865-017-0225-9

Ejemplares similares